Compare · BBLN vs HIMS
BBLN vs HIMS
Side-by-side comparison of Babylon Holdings Limited (BBLN) and Hims & Hers Health Inc. (HIMS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BBLN and HIMS operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- HIMS carries a market cap of $4.00B.
- HIMS has hit the wire 28 times in the past 4 weeks while BBLN has been quiet.
- HIMS has more recent analyst coverage (25 ratings vs 9 for BBLN).
- Company
- Babylon Holdings Limited
- Hims & Hers Health Inc.
- Price
- -
- -
- Market cap
- -
- $4.00B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NYSE
- NYSE
- IPO
- 2019
- News (4w)
- 0
- 28
- Recent ratings
- 9
- 25
Babylon Holdings Limited
Babylon Holdings Limited operates as a digital healthcare company in the United Kingdom and internationally. Its digital-first platform provides with assistance to navigate the health system by connecting patients digitally to the clinicians. The company was founded in 2013 and is headquartered in London, the United Kingdom.
Hims & Hers Health Inc.
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers. It provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, as well as cosmetics and supplement products, primarily focusing on wellness, sexual health, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, collagen protein, biotin, and teas in the wellness category; moisturizer, fragrances, face wash, and anti-wrinkle creams in the skincare category; condoms and lubricants in the sexual health category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. It also offers medical consultation services; and engages in the wholesale of non-prescription product sales to retailers. Hims & Hers Health, Inc. is based in San Francisco, California.
Latest BBLN
- Babylon Holdings Limited filed SEC Form 8-K: Other Events
- Babylon Holdings Limited filed SEC Form 8-K: Other Events
- SEC Form NT 10-Q filed by Babylon Holdings Limited
- Babylon Holdings Limited filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Babylon Holdings Limited filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- SEC Form 25-NSE filed by Babylon Holdings Limited
- SEC Form 4 filed by Vnv Global Ab (Publ)
- SEC Form SC 13D/A filed by Babylon Holdings Limited (Amendment)
- SEC Form 4 filed by Vnv Global Ab (Publ)
- Babylon Holdings Announces Receipt Of Continued Listing Standards Notice From NYSE And Upcoming Delisting
Latest HIMS
- Chief Legal Officer Soleil Boughton sold $64,077 worth of shares (3,458 units at $18.53) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 311,190 units (SEC Form 4)
- Chief Policy Officer Deborah M. Autor sold $441,533 worth of shares (23,828 units at $18.53) as part of a pre-agreed trading plan, decreasing direct ownership by 33% to 48,961 units (SEC Form 4)
- Chief Financial Officer Oluyemi Okupe sold $65,189 worth of shares (3,518 units at $18.53) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 266,188 units (SEC Form 4)
- Hims & Hers Launches Peptides+, a New Clinically-Guided Specialty for Access to Personalized, Proactive Health
- Director Christopher D Payne converted options into 810 shares, increasing direct ownership by 2% to 35,673 units (SEC Form 4)
- Chief Legal Officer Soleil Boughton converted options into 42,262 shares and covered exercise/tax liability with 21,500 shares, increasing direct ownership by 7% to 314,648 units (SEC Form 4) (tax withholding)
- CTO Mohamed Elshenawy converted options into 188,286 shares and covered exercise/tax liability with 95,798 shares, increasing direct ownership by 50% to 278,044 units (SEC Form 4) (for withholding tax)
- Chief Medical Officer Patrick Harrison Carroll converted options into 25,927 shares and covered exercise/tax liability with 10,200 shares, increasing direct ownership by 8% to 213,574 units (SEC Form 4) (for tax liability)
- Chief Policy Officer Deborah M. Autor converted options into 39,974 shares and covered exercise/tax liability with 16,146 shares, increasing direct ownership by 49% to 72,789 units (SEC Form 4) (withholding obligation)
- Chief Operating Officer Michael Chi converted options into 69,769 shares and covered exercise/tax liability with 38,581 shares, increasing direct ownership by 7% to 487,848 units (SEC Form 4) (tax withholding)